Cysteamine bitartrate delayed-release (Procysbi®)
Procysbi® for the treatment of proven nephropathic cystinosis.
| NCPE Assessment Process | Completed |
| Rapid review received | 01/12/2015 |
| Rapid review completed | 15/12/2015 |
| Rapid Review Outcome | Full pharmacoeconomic assessment recommended at the submitted price |
| Full pharmacoeconomic assessment commissioned by HSE | 23/12/2015 |
| Pre-submission consultation with applicant | 22/05/2017 |
| Submission received from applicant | 13/07/2017 |
| Preliminary review sent to applicant | 22/08/2017 |
| NCPE assessment re-commenced | 29/08/2017 |
| Applicant factual accuracy check | 17/10/2017 |
| NCPE assessment re-commenced | 15/11/2017 |
| NCPE assessment completed | 15/11/2017 |
| NCPE assessment outcome | Reimbursement not recommended at the submitted price |
The HSE has approved reimbursement following confidential price negotiations; July 2019